476 related articles for article (PubMed ID: 22884328)
1. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.
Charizanis K; Lee KY; Batra R; Goodwin M; Zhang C; Yuan Y; Shiue L; Cline M; Scotti MM; Xia G; Kumar A; Ashizawa T; Clark HB; Kimura T; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Gomes-Pereira M; Gourdon G; Sakai N; Nishino S; Foster TC; Ares M; Darnell RB; Swanson MS
Neuron; 2012 Aug; 75(3):437-50. PubMed ID: 22884328
[TBL] [Abstract][Full Text] [Related]
2. Compound loss of muscleblind-like function in myotonic dystrophy.
Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
[TBL] [Abstract][Full Text] [Related]
3. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
4. Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy.
Chen G; Carter RE; Cleary JD; Reid TS; Ranum LP; Swanson MS; Ebner TJ
Neurobiol Dis; 2018 Apr; 112():35-48. PubMed ID: 29331264
[TBL] [Abstract][Full Text] [Related]
5. A muscleblind knockout model for myotonic dystrophy.
Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
[TBL] [Abstract][Full Text] [Related]
6. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
7. Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy.
Machuca-Tzili LE; Buxton S; Thorpe A; Timson CM; Wigmore P; Luther PK; Brook JD
Dis Model Mech; 2011 May; 4(3):381-92. PubMed ID: 21303839
[TBL] [Abstract][Full Text] [Related]
8. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
9. Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Thomas JD; Sznajder ŁJ; Bardhi O; Aslam FN; Anastasiadis ZP; Scotti MM; Nishino I; Nakamori M; Wang ET; Swanson MS
Genes Dev; 2017 Jun; 31(11):1122-1133. PubMed ID: 28698297
[TBL] [Abstract][Full Text] [Related]
10. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
[TBL] [Abstract][Full Text] [Related]
11. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
[TBL] [Abstract][Full Text] [Related]
12. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
13. MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.
Goodwin M; Mohan A; Batra R; Lee KY; Charizanis K; Fernández Gómez FJ; Eddarkaoui S; Sergeant N; Buée L; Kimura T; Clark HB; Dalton J; Takamura K; Weyn-Vanhentenryck SM; Zhang C; Reid T; Ranum LP; Day JW; Swanson MS
Cell Rep; 2015 Aug; 12(7):1159-68. PubMed ID: 26257173
[TBL] [Abstract][Full Text] [Related]
14. Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy.
Edokpolor KS; Banerjee A; McEachin ZT; Gu J; Kosti A; Arboleda JD; García PS; Wang ET; Bassell GJ
eNeuro; 2022; 9(5):. PubMed ID: 36150891
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function.
Nitschke L; Hu RC; Miller AN; Lucas L; Cooper TA
Nucleic Acids Res; 2023 Feb; 51(3):1245-1259. PubMed ID: 36617982
[TBL] [Abstract][Full Text] [Related]
16. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
[TBL] [Abstract][Full Text] [Related]
17. Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
Wang LH; Lin CY; Lin YM; Buée L; Sergeant N; Blum D; Chern Y; Wang GS
J Neurosci; 2022 Jun; 42(25):5102-5114. PubMed ID: 35606145
[TBL] [Abstract][Full Text] [Related]
18. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Batra R; Charizanis K; Manchanda M; Mohan A; Li M; Finn DJ; Goodwin M; Zhang C; Sobczak K; Thornton CA; Swanson MS
Mol Cell; 2014 Oct; 56(2):311-322. PubMed ID: 25263597
[TBL] [Abstract][Full Text] [Related]
19. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
Pascual M; Vicente M; Monferrer L; Artero R
Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
[TBL] [Abstract][Full Text] [Related]
20. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
